T lymphocyte-targeted immunofusion protein
Alternative Names: Genimmune; Genimune; TIFLatest Information Update: 24 Oct 2021
At a glance
- Originator XOMA
- Class
- Mechanism of Action Immunosuppressants; T lymphocyte inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Autoimmune disorders; Leukaemia
Most Recent Events
- 14 Oct 2008 Discontinued - Preclinical for Autoimmune disorders in USA (IV-infusion)
- 14 Oct 2008 Discontinued - Preclinical for Leukaemia in USA (IV-infusion)
- 12 Mar 2002 Suspended - Preclinical for Autoimmune disorders in USA (IV-infusion)